IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bratton Capital Management, L.P.

Q2 2019 Holdings

Filed 2019-08-13 | 2 holdings | $48.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aquestive Therapeutics Inc(AQST)COM03843E104$48.3M11,503,294100.0%
Denali Therapeutics Inc(DNLI)COM24823R105$19.8K953,0350.0%